ArticleAmerican journal of epidemiology2026
Hypertensive disorders of pregnancy, maternal cardiovascular disease mortality and the role of familial predisposition: a Norwegian population-based sibling-comparison, sibling-spillover and negative-control cohort study.
Article in American journal of epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Long-term mortality in women with a history of hypertensive disorders of pregnancy: a systematic review and meta-analysis.EClinicalMedicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Hypertensive disorders of pregnancy (HDP) are associated with increased maternal cardiovascular disease (CVD) mortality, with risks varying by HDP subtypes and subsequent pregnancy outcomes. The contribution of shared familial factors given this heterogeneity is unclear. We conducted a population-based study using Norwegian registries (1967-2020) including 1 106 658 women with complete pregnancy histories, of whom 628 345 had at least one full sibling. Women with HDP were classified into low-risk (gestational hypertension or term pre-eclampsia followed by no HDPs) and high-risk (all other patterns) trajectories. CVD mortality before age 70 was assessed using population-level and sibling-based models: sibling-comparison (discordant-sisters), sibling-spillover (by sister's HDP history), and negative-control models (by sister-in-law's HDP history). CVD mortality among women with HDP varied by trajectory (population-level adjusted hazard ratios [aHR]low-risk 1.03 [95% confidence intervals, 0.89-1.20]; aHRhigh-risk 1.89 [1.74-2.06]). These differences persisted when compared to sisters without HDP (sibling-comparison aHRlow-risk 0.66 [0.44-1.01]; aHRhigh-risk 1.51 [1.16-1.97]). Women without HDP had slightly elevated CVD mortality if sisters had HDP (sibling-spillover aHRlow-risk 1.28 [1.03-1.60]; aHRhigh-risk 1.25 [1.06-1.49]), but not if sisters-in-law had HDP (negative-control aHRlow-risk 1.10 [0.85-1.40]; aHRhigh-risk 1.01 [0.83-1.22]). Individual-specific factors drive the CVD mortality heterogeneity among women with HDP. Shared familial factors modestly elevate CVD mortality in women without HDP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.